| LATEST NEWS | Westports posts RM998.31 million net profit in FY2025 versus RM897.98 million in FY2024 | Maj Gen Mohamed Fauzi pleads not guilty to RM5 mln CBT charge involving Armed Forces Welfare Fund | |
KUALA LUMPUR, Oct 18 (Bernama) - The government allocated RM470 million for financing funds provided by SME Bank, Bank Simpanan Nasional, Bank Rakyat and MARA to support women's micro, small and medium enterprises (PMKS) obtain working capital, purchase assets and increase business capacity to a higher level.
KUALA LUMPUR, Oct 16 (Bernama) -- A total of 6,617 battery-powered electric vehicles (BEVs) were sold in the first half of 2024 (1H2024) marking a significant 112 per cent year-on-year surge in the electric vehicle (EV) market, said Minister of Investment, Trade and Industry Tengku Datuk Seri Zafrul Abdul Aziz.
KUALA LUMPUR, Oct 15 (Bernama) -- The Malaysian Investment Development Authority (MIDA) is actively crafting innovative and strategic pathways, connecting investors and industry players with local talent to meet the ever-evolving demands of the industry.
KUALA LUMPUR, Oct 8 (Bernama) -- Trilliant has introduced Analytics as a Service (AaaS), a new offering that enables utilities worldwide to further leverage data by providing deeper insights and understanding of that data at Enlit Asia 2024.
KUALA LUMPUR, Oct 4 (Bernama) -- According to the Malaysia Semiconductor Industry Association (MSIA), 53 per cent of companies in the electrical and electronics (E&E) and semiconductor sectors are optimistic about the business outlook for the fourth quarter of 2024 (4Q).
KUALA LUMPUR, Sept 24 (Bernama) -- The Malaysian Consultative Council of Islamic Organisations (MAPIM) has called on all parties, regardless of political ideology, to support the MADANI Government’s efforts to revitalise and strengthen the national economy in the current situation where the ringgit continues to strengthen.
By Durratul Ain Ahmad Fuad
KUALA LUMPUR, Sept 15 (Bernama) – Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.
